RBA Wealth Management’s Eli Lilly LLY Stock Holding History

RBA Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90	Closed	-$16.8K	–	177
2021 Q1	$16.8K	Buy	+90	New	+$17.6K	0.01%	125

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

RBA Wealth Management's LLY Position: Q2 2021 in Review

RBA Wealth Management sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 90 shares — an estimated $16.8K sold.

RBA Wealth Management first reported a position in LLY in Q1 2021 and held it in 1 quarter. The position peaked at $16.8K in Q1 2021. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

RBA Wealth Management reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
RBA Wealth Management sold 90 Eli Lilly shares in Q2 2021, an estimated $16.8K.
RBA Wealth Management first reported a position in Eli Lilly in Q1 2021 and held it in 1 quarter.
RBA Wealth Management's Eli Lilly position peaked at $16.8K in Q1 2021.
2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on RBA Wealth Management's 13F filing for Q2 2021, filed 22 Jul 2021.